14th May 2009 07:00
BEXIMCO PHARMACEUTICALS LTD.
17, DHANMONDI R.A, ROAD NO. 2,
DHAKA-1205
|
News Release |
May 14, 2009 |
NOTICE OF THE THIRTY-THIRD ANNUAL GENERAL MEETING
Notice is hereby given that the THIRTY-THIRD ANNUAL GENERAL MEETING of the Shareholders of Beximco Pharmaceuticals Limited will be held on Tuesday, 16th June, 2009 at 9.30 a.m. at 1, Shahbag C/A, Dhaka, to transact the following business:
Agenda
1. To receive, consider and adopt the Audited Financial Statements of the Company for the year ended 31st December 2008, together with reports of the Auditors and the Directors thereon.
2. To elect Directors.
3. To confirm the appointment of Mr. Nazmul Hassan as Managing Director of the Company for a period of 5 years effective from 7th May 2009.
4. To declare 10% Cash and 20% Stock Dividend.
5. To appoint Auditors for the year 2009 and to fix their remuneration.
6. To transact any other business of the Company with the permission of the Chair.
By order of the Board,
Sd/-
( MD. ASAD ULLAH, FCS )
Company Secretary
NOTES
(1) The Record Date shall be on 25th May, 2009. The Shareholders whose names will appear in the Share Register of the Company or in the Depository Register on that date will be entitled to attend the Annual General Meeting and to receive the dividend.
(2) A member entitled to attend and vote at the General Meeting may appoint a Proxy to attend and vote in his/her stead. The Proxy Form, duly stamped, must be deposited at the Registered office of the Company not later than 48 hours before the time fixed for the meeting.
(3) Admission to the meeting room will be strictly on production of the attendance slip sent with the Notice as well as verification of signature of Member(s) and/or proxy-holder(s).
For further enquiries please contact:
Beximco Pharma
Nazmul Hassan, CEO
MD. ASAD ULLAH, FCS, Company Secretary
Tel: +880 2 861 9151, ext.2080
Libertas Capital
Jakob Kinde / Anthony Rowland
Tel: +44 (0)20 7569 9650
Financial Dynamics
Jonathan Birt / Susan Quigley
Tel: +44 (0)20 7269 7169
Notes to Editors
About Beximco Pharmaceuticals Limited
Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids. The Company also manufactures and markets its own branded generics for almost all diseases. The Company also undertakes contract manufacturing for multinational pharmaceutical companies. The Company operates from a 20 acre site in Dhaka and currently employs over 2,400 staff.
The Company's products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in East Africa, Pacific Island and Central American countries and South East Asia, including Singapore and Hong Kong.
Related Shares:
Beximco Pharma